University of Aberdeen, and the Royal Infirmary, Aberdeen SYNOPSIS A simple and rapid method has been developed for the simultaneous separationl and semi-quantitative estimation of formimino-glutamic and urocanic acids in urine. The urinary excretion of these compounds in a group of normal subjects and in a number of illustrative cases has been determined. In view of current opinion that it is the total of these two metabolites of histidine which is the significant figure in clinical investigation, their simultaneous separation and measurement is an important advantage of the method.
Deficiency of the folic acid coenzymes required in the final stages of histidine breakdown to glutamic acid ( Fig. 1 ) may lead to increased urinary excretion of formimino-glutamic acid (FIGLU) (Bakerman, Silverman, and Daft, 1951; Borek and Waelsch, 1953) . Estimation of urinary FIGLU has, therefore, become accepted clinical practice for the evaluation of megaloblastic anaemias in man. A variety of methods, quantitative and semi-quantitative, has been recommended. These include electrophoresis by low (Kohn, Mollin, and Rosenbach, 1961) and high (Knowles, Prankerd, and Westall, 1960) voltage; paper chromatography Teller, 1959a, 1959b) ; and enzymatic (Tabor, and Wyngarden, 1958) and microbiological (Silverman, Gardiner, and Condit, 1958) assays. The sensitivity of the methods has been increased by preliminary histidine loading (Tabor, Silverman, Mehler, Daft, and Bauer, 1953 These facts make it desirable in clinical work to estimate both FIGLU and urocanic acid. The method devised for this purpose by Chanarin and Bennett (1962) requires the preparation of a crude liver enzyme. This is tedious and time-consuming, and in our hands, at least, has not been invariably successful. Moreover, as Cooperman and Luhby (1962) Urine, 5 p1., was applied to duplicate cellulose plates, and both were run for 2 5 hours in n-butanol:glacial acetic acid:water (114:38:60). One of the plates was dried in a fan-operated oven at 50°C. for 25 minutes and then exposed to ammonia vapour in a tank (beaker of ammonia solution AnalaR sp. gr. 0-88 in the bottom of the tank) for 60 minutes in order to convert FIGLU to glutamic acid. The other (control) was left untreated, and allowed to dry in an atmosphere as ammonia-free as possible. The ammonia-treated plate was placed in the fan-operated oven for 10 to 15 minutes to drive off excess ammonia, then allowed to cool.
LOCATION OF COMPOUNDS Amino-acids were detected by spraying the plates with 0-2% ninhydrin (AnalaR) in acetone, a drop of pyridine being added to the reagent for increased sensitivity. FIGLU appeared as a purple spot on the ammonia-treated plate after decomposition to glutamic acid. The intensity of this spot was maximal after about one hour at room temperature. The appearance of the plate at one hour could be preserved by spraying with 0-25 M nickel sulphate. Urocanic acid was revealed as an orange-red spot after spraying with Pauly reagent (Smith, 1960 (Neill and Weaver, 1958; Todd, 1959 (Fig. 3a) shows that the marker urine also contains urocanic acid, the estimated concentration from comparison with the standards being about 50 ,ug./ml.
TEST URINES Table I summarizes the results of the urinary excretion of histidine metabolites after a histidine load of 5 to 15 g. in eight normal subjects, five patients with megaloblastic anaemia due to vitamin B12 and/or folic acid deficiency, and a patient with erythraemic myelosis. Case 9 is of particular interest in the light of the recent report (Forshaw, Harwood, and Weatherall, 1964) Case 10 with pernicious anaemia showed a satisfactory haematological response to vitamin B12 and the serial reduction in the amount of abnormal histidine metabolites followed the pattern previously described (Chanarin, 1963 'In view of the semi-quantitative nature of the estimation, the calculated total excretion is expressed as follows:-3-5 mg. as 5 mg., 6-50 mg. to nearest 5 mg., 51-100 mg. to nearest 10 mg., 
group.bmj.com on August 28, 2017 -Published by http://jcp.bmj.com/ Downloaded from able interest in the amounts of abnormal histidine metabolites excreted by this patient. Objective evidence of folic acid deficiency has not, to our knowledge, previously been described in erythraemic myelosis, although theoretically such a deficiency might be expected considering the hyperplastic, though deranged and ineffective, erythropoiesis that is the hallmark of this disease. During our 18-month period of observation serum vitamin B12 levels and radio-cobalt vitamin B12 absorption tests were all normal on three separate occasions, the last series of tests having been carried out at the time of the histidine load tests. It should be noted that the abnormal excretion in this patient is accounted for almost exclusively by urocanic acid. Marked improvement in the excretory pattern occurred with 15 mg. folic acid daily by mouth; complete reversal to normal, however, was not obtained until the same dose was given by intramuscular injections on each of three successive days. This case is shortly to be reported in greater detail elsewhere.
DISCUSSION
The method described using thin-layer chromatography for the simultaneous separation and detection from urine of FIGLU and urocanic acid has proved to be relatively simple, consistent, and reproducible. FIGLU down to 0 125 ,ug. and urocanic acid down to 0-0625 ,ug. can be detected, and the amounts present in urine can be roughly quantitated by comparison with standards run at the same time. Thin-layer chromatography, now very widely used for rapid separations, is a simpler process to carry out than high voltage electrophoresis, and the sensitivity is just as good, if not better, with the former technique. Enzymatic techniques are, of course, more sensitive, but are difficult and take much longer to carry out.
The new technique has been applied very successfully to many normal and abnormal urines and the results in six representative cases are briefly described. A feature of the method is that FIGLU and urocanic acid can be estimated simultaneously. If, as claimed by Bennett and Chanarin (1962) , it is the total of these two metabolites which is the clinically significant figure, this is an important advantage of the technique.
The main disadvantage of the method as it stands is the lack of precise quantitation. It is hoped to develop the method into one more strictly quantitative by eluting the FIGLU and urocanic acid from the cellulose and measuring their coloured derivatives spectrophotometrically. For general screening purposes and for following the results of specific therapy, rough quantitation by visual inspection of the spots against standards seems to be satisfactory.
